The foreseeability of real anti-aging medicine: focusing the debate

被引:43
作者
de Grey, ADNJ [1 ]
机构
[1] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England
关键词
anti-aging medicine; reversing aging; retarding aging; policy implications; biotechnology; evolution;
D O I
10.1016/S0531-5565(03)00155-4
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
There has recently been a sharp and very welcome increase in the rate of appearance of articles discussing the concept of medical interventions that would greatly increase the maximum healthy human lifespan. Much of this literature has emphasised the current non-existence of any such therapies, and has done so with laudable accuracy and authority. Regrettably, however, such articles have frequently extended their ambit to include the issues of how soon such interventions could be developed and of how advisable such an effort would be anyway, and have addressed these much more weakly, thereby diminishing the force of their main message. Here a survey is made of the more conspicuously flawed arguments suggesting tremendous difficulties or dangers in developing such interventions, with the aim thereby to tow those arguments firmly out into the ocean and give them the decent but unambiguous public burial that they so richly deserve. It is hoped that, by clearing the debate on future anti-aging advances of these obfuscations, the many aspects of this topic that have hitherto received much less attention than they warrant will be brought to the fore. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:927 / 934
页数:8
相关论文
共 37 条
[1]  
[Anonymous], WORLD POP PROSP 2000
[2]  
Björklund A, 2000, NOVART FDN SYMP, V231, P7
[3]   Biological evidence for limits to the duration of life [J].
Carnes, BA ;
Olshansky, SJ ;
Grahn, D .
BIOGERONTOLOGY, 2003, 4 (01) :31-45
[4]   Fear of misrepresentation cannot justify silence about foreseeable life-extension biotechnology [J].
de Grey, A .
BIOESSAYS, 2003, 25 (01) :94-95
[5]  
de Grey ADN, 2002, SCIENCE, V296, P656
[6]   Mitochondrial gene therapy: an arena for the biomedical use of inteins [J].
de Grey, ADNJ .
TRENDS IN BIOTECHNOLOGY, 2000, 18 (09) :394-399
[7]   Challenging but essential targets for genuine anti-ageing drugs [J].
de Grey, ADNJ .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2003, 7 (01) :1-5
[8]   Bioremediation meets biomedicine: therapeutic translation of microbial catabolism to the lysosome [J].
de Grey, ADNJ .
TRENDS IN BIOTECHNOLOGY, 2002, 20 (11) :452-455
[9]   Time to talk SENS: Critiquing the immutability of human aging [J].
De Grey, ADNJ ;
Ames, CN ;
Andersen, JK ;
Bartke, A ;
Campisi, J ;
Heward, CB ;
McCarter, RJM ;
Stock, G .
INCREASING HEALTHY LIFE SPAN: CONVENTIONAL MEASURES AND SLOWING THE INNATE AGING PROCESS, 2002, 959 :452-462
[10]   Is human aging still mysterious enough to be left only to scientists? [J].
de Grey, ADNJ ;
Baynes, JW ;
Berd, D ;
Heward, CB ;
Pawelec, G ;
Stock, G .
BIOESSAYS, 2002, 24 (07) :667-676